FAQ

Home               

 

  Home

Hours, Appointments, Directions to Office, and Staff
About Dr. Kimberly Larson-Ohlsen, MD
Ob - Information, Education and Services for Pregnancy
Gyn - Information, Education and Services for Women's Health
Infertility - Information, Education and Services
Insurance and Payment Plans and Information
Hospitals Affiliated with the Practice
Contact Us for More Information
Frequently Asked Questions

Thursday, May 15, 2008

 
Breast Cancer

At what age should I start thinking about breast cancer?

What is a woman’s risk of getting breast cancer?

What are the odds of getting and surviving breast cancer?

What are the risk factors for developing breast cancer?

What does it mean to have a genetic predisposition to breast cancer?

What medical procedures are recommended for the early detection of this disease?

What are some factors in breast cancer treatment and recovery?

What are the treatments for breast cancer?

What is a clinical trial and should I become part of one?

 

     Also See:

                   Breast Self Exam

                   Early Stage Breast Cancer
                 
 Cancer
                   Mammograms

 

Return to Frequently Asked Questions Index

 


At what age should I start thinking about breast cancer?

Although 80 percent of breast cancers occur in women older than age 50, it is important for a young woman to examine her breasts so that she will know what feels "normal" for finding changes during breast self-exams later in life. Most breast cancers (70%) are self-detected.

 


 

What is a woman’s risk of getting breast cancer?

 

Breast cancer is the most common form of cancer (other than skin) in American women and the second major cause of death after lung cancer. One out of 8 women will develop breast cancer over the course of a lifetime.

 


What are the odds of getting and surviving breast cancer?

Many survival and risks of incidence are correlated with the age of the patient and the stage of the cancer when discovered. A report from the National Cancer Institute (NCI) estimates that about 1 in 8 women in the United States will develop breast cancer during her lifetime.

The present estimate is higher than the 1-in-9 figure reported previously by the American Cancer Society (ACS), primarily due to the inclusion of the oldest age groups in the new calculations. The 1-in-9 estimate used a cutoff age of 85 years, but the new 1-in-8 figure (approximately 12.6 percent) includes all age groups in 5-year intervals up to an open-ended interval of 95 years and over. Each age interval is assigned a weight in the calculations based on the proportion of the population living to that age. The probability of developing breast cancer before age 85 remains approximately 1 in 9.

Survival rates really depending on a combination of health status, age, stage of the cancer and other factors. See your physician for your own personal health assessment.

 


 

What are the risk factors for developing breast cancer?

 

Risk is increased with age, such that 80 percent of women with breast cancer are over age 50. Women who have a history of breast cancer in the family, who never have had children, who had a first child after age 30, who began menstruation before age 12 or who complete menopause after age 55 are also at increased risk of breast cancer. Heavy alcohol consumption and obesity have also been shown to increase the risk of breast cancer.


 

What does it mean to have a genetic predisposition to breast cancer?

 

Genes contain the hereditary information that is passed down from parent to child. They serve as the blueprint for many features. Everyone has two copies of a gene called BRCA1 in the cells of their body, one inherited from their mother and one from their father. In most people, both BRCA1 genes function normally. But in some individuals, one copy carries a misspelling. This change, or alteration, can occur at hundreds of different sites along the BRCA1 gene. Some of these changes make a person more at risk for developing breast or ovarian cancer, and may possibly be associated with cancers of the colon and prostate.

In a recent research study, one particular alteration in BRCA1, known as 185delAG, was found to occur more frequently in a group of Jews of Eastern European descent (Ashkenazi Jews) than among other ethnic groups in the study. Approximately 1 percent of Ashkenazi individuals were found to carry this alteration in this preliminary study. The National Cancer Institute and the National Center for Human Genome Research will soon begin another research study of the Ashkenazi Jewish population to determine exactly how common this alteration is and how often this alteration is related to the incidence of breast cancer and ovarian cancer.

What we know and don't know about BRCA1 alterations:

Known: Most people who develop breast cancer, including those in the Jewish population, have normal BRCA1 genes. In fact, only about 5-10 percent of all breast cancer cases appear to be inherited and not all of these are related to BRCA1. BUT, Although certain to be fairly low, the exact percentage of inherited breast and ovarian cancers in the Jewish population is not known.

Known: Women with a strong family history of breast and/or ovarian cancer who have inherited an alteration in BRCA1 have a substantial risk of developing breast and/or ovarian cancer. This often occurs at an unusually early age, for instance, before menopause. BUT, The cancer risks for an individual without a strong family history who is found to carry the 185delAG alteration is not known. There are other factors such as lifestyle, hormonal factors, environmental influences, and other inherited traits that affect cancer risks. As testing for alterations in the BRCA1 gene becomes available to researchers, the interaction of these factors can be studied.

Known: Not all women who carry the BRCA1 alteration will develop breast or ovarian cancer BUT, the alteration is not the single cause of disease, only a contributing factor. There must be other factors, yet unknown, that affect the development of cancer in addition to having an altered BRCA1 gene. Therefore, people who carry the altered gene are said to have a susceptibility to breast and ovarian cancer.

Known: If a woman tests negative for an alteration in BRCA1, she may still get breast cancer. On average, a woman has a one in eight lifetime risk of developing breast cancer. BUT, All the genes that may increase a woman's risk of breast and ovarian cancer have not been identified and, therefore, cannot be tested for.

 


 

What medical procedures are recommended for the early detection of this disease?

 

As a matter of routine, women should perform monthly breast self-examinations, go for a breast exam by a doctor or nurse, and have a mammogram (an x-ray picture of the breast that can detect breast cancer when it is in its earliest, most treatable stage, up to 2 years before a lump can be felt) performed every 1 to 2 years. This will increase the chance of discovering breast cancer early. When detected and treated at an early stage, chances for survival will increase and the woman will have more options for treatment.

 


 

What are some factors in breast cancer treatment and recovery?

 

Your chance of recovery (prognosis) and choice of treatment depend on the stage of your cancer (the size of the tumor and whether it is just in the breast or has spread to other places in the body), the type of breast cancer, certain characteristics of the cancer cells, and whether the cancer is found in your other breast. Your age, weight, menopausal status (whether or not you still have menstrual periods), and general health can also affect your prognosis and choice of treatment.

 


 

What are the treatments for breast cancer?

 

There are treatments for all patients with breast cancer. Four types of treatment are used: surgery (taking out the cancer in an operation), radiation therapy (using high-dose x-rays to kill cancer cells), chemotherapy (using drugs to kill cancer cells), and hormone therapy (using hormones to stop the cells from growing). Biological therapy (using your body’s immune system to fight cancer) and bone marrow transplantation are now being tested in clinical trials. Several treatments may be combined, and specific treatment recommendations depend on the type and location of the tumor, the stage at which it has been detected, and the patient’s age and general health.

 


 

What is a clinical trial and should I become part of one?

 

Before you start treatment for breast cancer, you may want to think about taking part in a clinical trial, a study that uses new treatments to care for patients. Each study is based on past studies and on what has been learned in the laboratory. Clinical trials are undertaken to find new and better ways to help cancer patients. If clinical trials show that the new treatment is better than the treatment currently being used, the new treatment may become the standard treatment.

 

 

from The Office On Women's Health - US Department of Health and Human Services

 

 

Return to Frequently Asked Questions Index

 

  

 

Our Office | Physician | Obstetrics Care | Gynecology Care | Infertility Care | Insurance & Payment

Hospital Affiliations | Contact Us | Frequently Asked Questions | Useful Links

 

 


 

The recommendations and information provided by this Web site are designed for educational purposes only. 

This information is not intended to be a substitute for medical care from your physician. 

Always consult your physician regarding your specific condition, concerns, and questions.

Copyright © 2002 - 2006, Kimberly Larson-Ohlsen, M.D., P.C. All Rights Reserved.
1550 S. Potomac St. · Suite 340 · Aurora, CO 80012 · Tel: 303.797.7227 · Fax: 303.797.8448